The impact of clinicopathological parameters in predicting response to pegylated interferon and ribavirin in chronic hepatitis C patients

dc.contributor.author	Yousef Assad, Nancy
dc.contributor.author	Ahmed Ehsan, Nermine
dc.contributor.author	Gaber Abdou, Asmaa
dc.contributor.author	Ahmed El-Tahmody, Mohamed
dc.contributor.author	Mohamed El-Sabaawy, Maha
dc.contributor.author	Farag El-Naidany, Nada
dc.contributor.author	Saad El-Kholy, Shimaa
dc.date.accessioned	2020-03-17T07:37:22Z
dc.date.available	2020-03-17T07:37:22Z
dc.date.issued	2014
dc.identifier.issn	1110-2098
dc.identifier.other	https://doi.org/10.4103/1110-2098.149768
dc.identifier.uri	https://cutt.ly/utjSj7P
dc.description	MSA Google Scholar	en_US
dc.description.abstract	This study aimed to investigate the impact of clinical and histopathological changes in liver tissue of responders and nonresponders to standard pegylated interferon (Peg-IFN) and ribavirin (RBV) therapy and to determine whether they could predict treatment outcome or no	en_US
dc.description.sponsorship	Medknow Publications	en_US
dc.language.iso	en	en_US
dc.publisher	Medknow Publications	en_US
dc.relation.ispartofseries	Menoufia Medical Journal;VOL : 27 Issue : 4
dc.subject	Chronic hepatitis C	en_US
dc.subject	histopathological changes impact	en_US
dc.subject	interferon	en_US
dc.subject	response to therapy	en_US
dc.title	The impact of clinicopathological parameters in predicting response to pegylated interferon and ribavirin in chronic hepatitis C patients	en_US
dc.type	Article	en_US
dc.identifier.doi	https://doi.org/10.4103/1110-2098.149768
dc.Affiliation	October University for modern sciences and Arts (MSA)